Traumatic Brain Injury ( TBI) is one of the most common cause of morbidity and mortality in young adults and can develop during early as well as late phase in life. TBI biomarkers measured in acute period would be useful for patients at risk of long-term disabilities and for physicians guiding pharmacological interventions. Such biomarkers are well studied and some of them are already applied to clinical practices. Here, we review some of the most studied TBI biomarkers.
TBI is present in all societies across the world and is the most severe, disabling neurological disorder affecting 57 million patients across the globe. TBI is one of the most common cause of morbidity and mortality in young adults less than 45 years of age and can develop during early as well as late phase in life. According to the World Health Organization, TBI will rank as a major cause of death and disability by…
